Launches First-In-Human Study on Non-Invasive Thyroid Cancer Diagnostic Medical Device

The study is being led by Prof. Dr. Marco Caversaccio, PD Dr. Urs Borner and Dr. Samuel Tschopp, in cooperation with Prof. Roman Trepp (Endocrinology) and Prof. Reto Kaderli (Visceral Surgery).

Compremium is collaborating with researchers at Bern University Hospital, to investigate a new, non-invasive diagnostic medical device for thyroid nodules. The first-in-human clinical study will evaluate whether measuring tissue compressibility can provide additional information for clinical decision-making.

“This study will help us explore whether measuring the compressibility of thyroid nodules could provide additional information for clinical decision-making. By assessing the characteristics of thyroid nodules in real time, we aim to minimize invasive procedures and improve patient care through risk-adapted monitoring.”

link: News - Compremium - Compremium Launches First-In-Human Study on Non-Invasive Thyroid Cancer Diagnostic Medical Device